News Center

位置：

Honors Announcement

Group News

Media Reports

Public Notice of the Draft Environmental Impact Assessment Report for the Technological Upgrade Project of the Active Pharmaceutical Ingredient Workshop at Hebei Guolong Pharmaceutical Co., Ltd.

Category:

Honors Announcement

发布时间：2024-07-31

【概要描述】 Our company has completed the preparation of the “Environmental Impact Report for the Technical Renovation Project of the Active Pharmaceutical Ingredient Workshop at Hebei Guolong Pharmaceutical Co., Ltd.” (Draft for Public Comment). In accordance with the requirements of the Environmental Impact Assessment Law of the People’s Republic of China and the Measures for Public Participation in Environmental Impact Assessment (Order No. 4 of the Ministry of Ecology and Environment), we hereby make the following information public and solicit further comments and suggestions from citizens, legal entities, and other organizations within the scope of the assessment regarding the environmental impacts of the proposed project and the associated environmental protection measures.

Public Notice of the Draft Environmental Impact Assessment Report for the Technological Upgrade Project of the Active Pharmaceutical Ingredient Workshop at Hebei Guolong Pharmaceutical Co., Ltd.

Our company has completed the preparation of the “Environmental Impact Report for the Technical Renovation Project of the Active Pharmaceutical Ingredient Workshop at Hebei Guolong Pharmaceutical Co., Ltd.” (Draft for Public Comments). In accordance with the requirements of the Environmental Impact Assessment Law of the People’s Republic of China and the Measures for Public Participation in Environmental Impact Assessment (Order No. 4 of the Ministry of Ecology and Environment), we hereby make the following information public and solicit further comments and suggestions from citizens, legal entities, and other organizations within the scope of the assessment on the environmental impacts of the proposed project and the associated environmental protection measures.

I. Name and Overview of the Construction Project

Project Name: Technical Renovation Project for the Active Pharmaceutical Ingredient Workshop of Hebei Guolong Pharmaceutical Co., Ltd.

Construction Entity: Hebei Guolong Pharmaceutical Co., Ltd.

Construction Address: Southeast Corner at the Intersection of Xingye Street and Three Gorges Road, Shijiazhuang Economic and Technological Development Zone

Project nature: Technological upgrade

Total investment: RMB 3 million

Main construction components: leveraging existing workshops and utility facilities, procuring additional equipment, and carrying out technological upgrades to the existing API production line. Upon completion of the project, the output and product portfolio of APIs that are not subject to import or export restrictions will be adjusted, resulting in a 20.967 t/year increase in production capacity over the original level.

II. Online link to the full draft Environmental Impact Report for public comment, as well as methods and channels for accessing the hard copy of the report

The public may download and review the “Environmental Impact Assessment Report for the Technical Renovation Project of the Active Pharmaceutical Ingredient Workshop at Hebei Guolong Pharmaceutical Co., Ltd.” (Draft for Public Comments) online via the following link: https://pan.baidu.com/s/1oyi8VYJWwp9tQKLrR5BtCA?pwd=1234; extraction code: 1234. Alternatively, the public may visit the premises of Hebei Guolong Pharmaceutical Co., Ltd. to examine the hard-copy version of the report. Contact person: Wei Xiaowei; contact telephone: 18032935650.

III. Scope of the Public Consultation

Citizens, legal persons, and other organizations within the scope of the environmental impact assessment.

IV. Online Link to the Public Opinion Form

Link: https://pan.baidu.com/s/1oyi8VYJWwp9tQKLrR5BtCA?pwd=1234

V. Methods and Channels for Public Submission of Comments

The public may submit the “Public Opinion Form for Environmental Impact Assessment of Construction Projects,” duly completed in accordance with the requirements, to the project proponent by mail, email, fax, or other means. When submitting your comments, please provide detailed and accurate contact information so that we can promptly provide you with relevant feedback.

Contact information for the construction entity:

Construction Entity: Hebei Guolong Pharmaceutical Co., Ltd.

Contact: Wei Xiaowei

Contact number: 18032935650

Fax: 0311-67107152

Email: 821736359@qq.com

Address: Southeast corner at the intersection of Xingye Street and Sanxia Road, Shijiazhuang Economic and Technological Development Zone

VI. Environmental Impact Assessment Agency

Environmental Impact Assessment Agency: Guohuan Technology (Hebei) Co., Ltd.

VII. Period for Public Submission of Comments

The period for soliciting public comments shall be five working days from the date of this information disclosure.

Hebei Guolong Pharmaceutical Co., Ltd.

Keywords:

Shijiazhuang Sihua Pharmaceutical Group Launches Its First Three-Chamber Bag Infusion Product; “Infusion + Oral Solid” — Three Dosage Forms and Four Specifications of New Products Approved on the Same Day

A patent owned by Shijiazhuang Sihua Pharmaceutical Group’s Bosheng Medical Devices has been recognized as one of the Top Ten Invention Patents of Taizhou City’s Employees for 2024.